Common “First in Man” approaches vs. The Lost Art of Formulation Development

In today’s market, pharmaceutical and biotech companies are being asked to do more…with less.  Diminishing resources, pipelines, competition, and increased regulatory hurdles are forcing us to rethink our strategy. We must work smarter, not harder.